Mustafa Shakra

Abu Dhabi, AZ, United Arab Emirates

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Neurocysticercosis in a Non-Endemic Region: A Retrospective Cohort Study at Sheikh Khalifa Medical City (SKMC), Abu Dhabi, UAE.

Neurocysticercosis in a Non-Endemic Region: A Retrospective Cohort Study at Sheikh Khalifa Medical City (SKMC), Abu Dhabi, UAE.

Journal: Cureus
Published: May 30, 2025

Role of Immune Reconstitution Therapy with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in Older Patients.

Role of Immune Reconstitution Therapy with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in Older Patients.

Journal: Neurology and therapy
Published: April 08, 2025

Cost-effectiveness of ofatumumab for the treatment of relapsing forms of multiple sclerosis in the United Arab Emirates.

Cost-effectiveness of ofatumumab for the treatment of relapsing forms of multiple sclerosis in the United Arab Emirates.

Journal: Therapeutic advances in neurological disorders
Published: July 16, 2024

Position of Cladribine Tablets in the Management of Relapsing-Remitting Multiple Sclerosis: An Expert Narrative Review From the United Arab Emirates.

Position of Cladribine Tablets in the Management of Relapsing-Remitting Multiple Sclerosis: An Expert Narrative Review From the United Arab Emirates.

Journal: Neurology and therapy
Published: February 05, 2021

High-efficacy therapies for relapsing-remitting multiple sclerosis: implications for adherence. An expert opinion from the United Arab Emirates.

High-efficacy therapies for relapsing-remitting multiple sclerosis: implications for adherence. An expert opinion from the United Arab Emirates.

Journal: Neurodegenerative disease management
Published: May 23, 2020

The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective.

The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective.

Journal: Therapeutic advances in neurological disorders
Published: November 26, 2019

Multiple Sclerosis in the Emirati Population: Onset Disease Characterization by MR Imaging.

Multiple Sclerosis in the Emirati Population: Onset Disease Characterization by MR Imaging.

Journal: Multiple sclerosis international
Published: May 23, 2019

An Overview of High-Efficacy Drugs for Multiple Sclerosis: Gulf Region Expert Opinion.

An Overview of High-Efficacy Drugs for Multiple Sclerosis: Gulf Region Expert Opinion.

Journal: Neurology and therapy
Published: October 16, 2018

Potential factors impacting health-related quality of life among patients with epilepsy: Results from the United Arab Emirates.

Potential factors impacting health-related quality of life among patients with epilepsy: Results from the United Arab Emirates.

Journal: Seizure
Published: August 04, 2017

Depression and anxiety as determinants of health-related quality of life in patients with multiple sclerosis - United Arab Emirates.

Depression and anxiety as determinants of health-related quality of life in patients with multiple sclerosis - United Arab Emirates.

Journal: Neurology international
Published: August 04, 2017

Depression and Anxiety among Patients with Epilepsy and Multiple Sclerosis: UAE Comparative Study.

Depression and Anxiety among Patients with Epilepsy and Multiple Sclerosis: UAE Comparative Study.

Journal: Behavioural neurology
Published: August 07, 2015

Fatal coma in a young adult due to late-onset urea cycle deficiency presenting with a prolonged seizure: a case report.

Fatal coma in a young adult due to late-onset urea cycle deficiency presenting with a prolonged seizure: a case report.

Journal: Journal of medical case reports
Published: July 07, 2015
Showing 1-12 of 16

Last Updated: 09/26/2026